| SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking E Bowton, C Saunders, IA Reddy, NG Campbell, PJ Hamilton, LK Henry, ... Translational psychiatry 4 (10), e464-e464, 2014 | 152 | 2014 |
| Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder E Bowton, C Saunders, K Erreger, D Sakrikar, HJ Matthies, N Sen, ... Journal of Neuroscience 30 (17), 6048-6057, 2010 | 151 | 2010 |
| Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation D Sakrikar, MS Mazei-Robison, MA Mergy, NW Richtand, Q Han, ... Journal of Neuroscience 32 (16), 5385-5397, 2012 | 141 | 2012 |
| Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies WI Gonsalves, V Ramakrishnan, T Hitosugi, T Ghosh, D Jevremovic, ... JCI insight 3 (1), 2018 | 58 | 2018 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... The Lancet Haematology 9 (5), e340-e349, 2022 | 53 | 2022 |
| Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant O Kovtun, D Sakrikar, ID Tomlinson, JC Chang, X Arzeta-Ferrer, ... ACS chemical neuroscience 6 (4), 526-534, 2015 | 51 | 2015 |
| Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots O Kovtun, ID Tomlinson, DS Sakrikar, JC Chang, RD Blakely, ... ACS chemical neuroscience 2 (7), 370-378, 2011 | 46 | 2011 |
| Localization of cocaine analog [125I] RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter RA Vaughan, DS Sakrikar, ML Parnas, S Adkins, JD Foster, RA Duval, ... Journal of Biological Chemistry 282 (12), 8915-8925, 2007 | 40 | 2007 |
| A specific phosphorylation regulates the protective role of αA-crystallin in diabetes A Ruebsam, JE Dulle, AM Myers, D Sakrikar, KM Green, NW Khan, ... JCI insight 3 (4), 2018 | 36 | 2018 |
| A comprehensive protocol for multiplatform metabolomics analysis in patient-derived skin fibroblasts J Wilkins, D Sakrikar, XM Petterson, IR Lanza, E Trushina Metabolomics 15, 1-9, 2019 | 25 | 2019 |
| Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population DJ Lee, H El-Khoury, AC Tramontano, JB Alberge, J Perry, MI Davis, ... Blood Advances 8 (7), 1737-1746, 2024 | 11 | 2024 |
| Mass Spectrometry-Based Assessment of M protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma T Kubicki, D Dytfeld, D Barnidge, D Sakrikar, A Przybyłowicz-Chalecka, ... Blood, 2024 | 7 | 2024 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 6 | 2021 |
| QIP-MS: A specific, sensitive, accurate, and quantitative alternative to electrophoresis that can identify endogenous m-proteins and distinguish them from therapeutic … S North, D Barnidge, S Brusseau, R Patel, M Haselton, B Du Chateau, ... Clin. Chim. Acta 493, S379-S433, 2019 | 5 | 2019 |
| Prevalence of Monoclonal Gammopathies Including an Age-Related Monoclonal Gammopathy of Indeterminate Potential (MGIP) in a Racially Diverse US Population Screened by Mass … H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 2 | 2022 |
| Distinguishing Daratumumab from Endogenous Monoclonal Proteins in Serum from Multiple Myeloma Patients Using an Automated Mass Spectrometry System D Barnidge, D Sakrikar, T Kubicki, BA Derman, AJ Jakubowiak, G Lakos The Journal of Applied Laboratory Medicine, jfae142, 2024 | 1 | 2024 |
| Prevalence of Monoclonal Gammopathies Detected By Mass Spectrometry and Their Risk Factors Among Black Africans in South Africa DJ Lee, H El-Khoury, L Bertamini, JB Alberge, MI Davis, J Perry, ... Blood 140 (Supplement 1), 7228-7229, 2022 | 1 | 2022 |
| Persistence of Monoclonal Gammopathies in Serial Samples from a US Population-Based Screening Study H El-Khoury, L Bertamini, JB Alberge, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10101-10103, 2022 | 1 | 2022 |
| Serum free light chains in a racially diverse population including African Americans and populations from South Africa L Bertamini, JB Alberge, DJ Lee, H El-Khoury, S Kim, G Fleming, ... Blood Journal, blood. 2024026078, 2024 | | 2024 |
| Early Serum Protein Clonal Dynamics Preceding Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma Years before Diagnosis S Allam, F Chabrun, JB Alberge, G Fleming, S Kim, Y Konishi, ... Blood 144, 3279, 2024 | | 2024 |
R. D. BlakelyFlorida Atlantic UniversityVerified email at health.fau.edu